Plasma amyloid concentration in Alzheimer’s disease: Performance of a high-throughput amyloid assay in distinguishing Alzheimer’s disease cases from controls

Manuscript Number: 

20-0046R1

Author(s): 
Insa Feinkohl, Jochen Kruppa, Felix Menne, Oliver Peters, Tobias Pischon, Carola G. Schipke, Georg Winterer

Disclosures

Insa Feinkohl

  • Nothing to Disclose

Jochen Kruppa

  • Nothing to Disclose

Felix Menne

  • Nothing to Disclose

Oliver Peters

  • Consulting Fees:
    Biogen, Roche
    Lecture Fees:
    Roche
    Grants
    • Agency: 
      Biogen
      Dates: 
      2016-2020
    • Agency: 
      Roche
      Dates: 
      2017-2020
    • Agency: 
      Novartis
      Dates: 
      2018-2019
    • Agency: 
      Janssen
      Dates: 
      2017-2019
    • Agency: 
      Pharmatrophix
      Dates: 
      2017-2020

Tobias Pischon

  • Nothing to Disclose

Carola G. Schipke

  • Lecture Fees:
    One scientific lecture at a conference at the invitation of a commercial sponsor, received € 500,- and expenses.
    Patents/Royalties
    I am inventor in a patent: WO2017190834A8 I am an employee of Predemtec AG.

Georg Winterer

  • Nothing to Disclose